SKLB-03220
Product Specifications
CAS Number
2852050-29-2
Target
Histone Methyltransferase
Related Pathways
Chromatin/Epigenetic
Purity
0.97016
Bioactivity
SKLB-03220 is an orally bioavailable covalent inhibitor targeting the histone methyltransferase EZH2, an established oncology drug target involved in epigenetic regulation. SKLB-03220 is structurally based on the clinically approved EZH2 inhibitor tazemetostat and demonstrates the ability to abolish epigenetic H3K27me3 marks, thereby altering chromatin state and transcriptional activity. SKLB-03220 represents a potent small-molecule tool for cancer epigenetics research.
Smiles
O=C(C=C)NC1=CC=C(C(=C1)C=2C=C(C(=O)NCC=3C(=O)NC(=CC3C)C)C(=C(C2)N(CC)C4CCOCC4)C)C
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
AF1669 100 µg
Human Serpin A4/Kallistatin Affinity Purified Polyclonal Ab
Sign In for Pricing
View Details 
bsm-62448R-PerCP-Cy5.5 100 µL
CTBP2 Recombinant Antibody, PerCP-Cy5.5 Conjugated
Sign In for Pricing
View Details TL321047V 500 µL Each
EIF4E1B Human shRNA Lentiviral Particle (Locus ID 253314)
Sign In for Pricing
View Details OR1072249-01 100 mg
Methyl 5- (bromomethyl) thiophene-2-carboxylate
Sign In for Pricing
View Details